|Bid||136.37 x 900|
|Ask||136.38 x 1100|
|Day's Range||135.44 - 137.62|
|52 Week Range||97.65 - 146.10|
|Beta (3Y Monthly)||1.16|
|PE Ratio (TTM)||112.71|
|Earnings Date||Jul 22, 2019 - Jul 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||158.65|
Stock investors looking for a way to outperform amid the trade war's major upheaval should look at Goldman Sachs' Hedge Funds VIP list.
IQVIA Holdings Inc. , announced today that Ari Bousbib, chairman and chief executive officer, will speak at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019 at 10:40 a.m.
IQVIA Holdings Inc. , will host an Analyst and Investor Conference in New York City on Tuesday, June 18, 2019. Management will provide an update on the business, with presentations starting at 9:00 a.m.
IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of this life sciences segment from concept-to-market
On Monday, Beijing made it very clear — almost 5,000 U.S. products will face as high as 25 percent increase in tariffs.
Spending on all U.S. medicines increased 4.5 percent to $344 billion on a net price basis, despite lower price growth, due to higher patient use of new and protected brands. In 2018, 29 billion fewer morphine milligram equivalents (MMEs) were dispensed to patients on a volume basis compared to 2017. The steepest decline occurred in the “high-strength” formulations ( =90 MMEs/day), which declined by 61 percent since 2011.
Prescription opioid use in the U.S. was down 17% in 2018, marking the largest annual decline ever recorded, a study by research firm IQVIA Institute for Human Data Science finds.
IQVIA Holdings Inc. (“IQVIA”) (IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,100,000,000 in aggregate principal amount of senior notes due 2027 (the “notes”). The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general corporate purposes.
Moody's Investors Service ("Moody's") assigned a Ba3 rating to the proposed senior unsecured notes of IQVIA Inc. ("IQVIA"). There are no changes to IQVIA's existing ratings, including the Ba2 Corporate Family Rating, Ba2-PD Probability of Default Rating, and SGL-1 Speculative Grade Liquidity Rating.
IQVIA Holdings Inc. (“IQVIA”) (IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $1,100,000,000 in gross proceeds through an offering of senior notes due 2027. The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general corporate purposes. Certain statements in this press release are forward-looking statements.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! When you buy shares in a company, it's worth keeping in mind the possibility that it could fail...
IQVIA (IQV) delivered earnings and revenue surprises of 1.32% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
IQVIA (IQV) has an impressive earnings history having outperformed the Zacks Consensus Estimate in all of the last four quarters.
On a per-share basis, the Durham, North Carolina-based company said it had profit of 29 cents. Earnings, adjusted for one-time gains and costs, came to $1.53 per share. The results exceeded Wall Street ...
NEW YORK, NY / ACCESSWIRE / May 1, 2019 / IQVIA Holdings, Inc. (NYSE: IQV ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 1, 2019 at 9:00 AM Eastern Time. ...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.-- -- First-quarter revenue $2,684 million and Adjusted EBITDA $587 million GAAP Diluted Earnings per Share $0.29; Adjusted Diluted Earnings per Share $1.53 Record constant currency organic revenue growth of 7.0 percent in Technology & Analytics Solutions Record R&D Solutions LTM contracted Net Book-to-Bill 1.51x, excluding pass throughs R&D Solutions NTM ...
IQVIA (IQV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Insperity (NSP) first-quarter 2019 earnings benefit from worksite employee growth and effective management of pricing, direct cost programs and operating costs.